Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:07 AM
Ignite Modification Date:
2025-12-26 @ 11:07 AM
NCT ID:
NCT04017312
Eligibility Criteria:
Inclusion Criteria:
* Radiological diagnosis of Bronchiectasis based on high resolution chest CT scan
* History of at least 2 acute exacerbations or hospitalizations in the past 12 months
* Clinically stable for \>2 weeks prior to study entry
* FEV1 \>30% predicted
* Age18-80 years
* Signed informed consent
Exclusion Criteria:
* Diagnosis of Cystic Fibrosis
* History of bronchiectasis secondary to primary immunodeficiency
* Active pulmonary tuberculosis
* Active treatment of Non-Tuberculous Mycobacterium (NTM)
* Patients currently on home HFCWO treatment or home HFCWO treatment within the past 24 months
* Diagnosed comorbidity or medical indication that would prevent study completion
* History of pneumothorax within past 6 months
* History of hemoptysis requiring embolization within past 12 months
* Inability to perform HFCWO therapy or OPEP therapy as directed
* Pregnancy or lactation
* Inability or unwillingness to complete study visits or provide follow-up data as required by the study protocol
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04017312
Study Brief:
Protocol Section:
NCT04017312